WW domain containing E3 ubiquitin protein ligase 1
Zuletzt aktualisiert 8. Mai 2023
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The WWP1 gene provides instructions for making a protein that is found is many tissues. This protein has activity known as E3 ubiquitin ligase. Proteins with this activity are involved in the process that targets other proteins to be broken down (degraded) within cells. Protein degradation is a normal process that removes damaged or unnecessary proteins and helps maintain the normal functions of cells.
Normal function
The WWP1 gene provides instructions for making a protein that is found is many tissues. This protein has activity known as E3 ubiquitin ligase. Proteins with this activity are involved in the process that targets other proteins to be broken down (degraded) within cells. Protein degradation is a normal process that removes damaged or unnecessary proteins and helps maintain the normal functions of cells.
The WWP1 protein can attach (bind) to various other proteins and mark them for degradation or alteration. In particular, the WWP1 protein binds to an enzyme called PTEN. The PTEN enzyme acts as a tumour suppressor, which means that it helps regulate cell division by keeping cells from growing and dividing (proliferating) too rapidly or in an uncontrolled way. To function, the PTEN enzyme has to bind to another PTEN enzyme (dimerize). Binding of the WWP1 protein to the PTEN enzyme impairs the PTEN enzyme's ability to dimerize, impairing the enzyme's activity.
Conditions referring to this gene or chromosome
Other names
TGIF-interacting ubiquitin ligase 1
TIUL1
WW domain-containing E3 ubiquitin protein ligase 1
Related patient information and medicines

Patient information leaflet
Gesunde Ernährung
You can reduce your intake of trans fats by avoiding or reducing the amount of fried foods, high-fat snacks and ... A 2019 review by the SACN (The Scientific Advisory Committee on Nutrition) determined that reducing your intake of saturated fats lowers your risk of developing coronary heart disease, although there was no evidence that it reduces.

Patient information leaflet
Das Immunsystem
This leaflet gives a brief overview of the Immunsystem and how it works. A person with a weak immune system might have difficulty fighting off infections. In autoimmune diseases the body is unable to tell what is its own and what is foreign, so it attacks itself. Autoimmune diseases can attack any part of the body - eg, type 1 diabetes.

Patient information leaflet
Bluttests
The main reasons to know your Blutgruppe are if you need to have a blood transfusion or if you are pregnant. You cannot request a blood test just to know your blood group on the NHS. What is blood made up of. Blood cells These can be seen under a microscope and make up about 40% of the blood's volume. Blood cells are made in the bone marrow by.

Patient information leaflet
Nahrungsmittelallergie und -intoleranz
How common are reactions to... It is very difficult to know how common true food allergy really is. Studies tend to come up with very different figures. depending on how they are set up. They suggest that in the developed world anywhere between 1 and 17 people out of 100 haben a food allergy. People tend to report food allergy more often than it is.

Patient information leaflet
Flaschenernährung Ihres Babys
Follow-on formula This contains added calcium, iron and protein, and replaces lactose with corn... Babies over 6 months old don't actually need follow-on formula either, and manufacturers have been criticised by the World Health Organization (WHO) promoting it as ein sensible 'switch' von breast-feeding, particularly in third-world countries..
%20and%20Matcha%20together%3F/og.png)
Patient information leaflet
Kann ich Certican (Everolimus) und Matcha zusammen einnehmen?
Drinking matcha tea while taking Certican (everolimus) may increase the levels of the medication in dein bloodstream. This could lead to an increased risk of side effects, such as mouth ulcers, infections, or kidney problems. Why this happens Certican is broken down in the body by a specific enzyme (CYP3A4) and a transport protein.
Weiterführende Lektüre und Referenzen
- WW domain containing E3 ubiquitin protein ligase 1; MedlinePlus, National Library of Medicine.
- Lee YR, Chen M, Lee JD, Zhang J, Lin SY, Fu TM, Chen H, Ishikawa T, Chiang SY, Katon J, Zhang Y, Shulga YV, Bester AC, Fung J, Monteleone E, Wan L, Shen C, Hsu CH, Papa A, Clohessy JG, Teruya-Feldstein J, Jain S, Wu H, Matesic L, Chen RH, Wei W, Pandolfi PP. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019 May 17;364(6441):eaau0159. doi: 10.1126/science.aau0159.
- Lee YR, Yehia L, Kishikawa T, Ni Y, Leach B, Zhang J, Panch N, Liu J, Wei W, Eng C, Pandolfi PP. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition. N Engl J Med. 2020 May 28;382(22):2103-2116. doi: 10.1056/NEJMoa1914919.
- Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM, Lunardi A, Webster K, Ng C, Newton RH, Knoblauch N, Guarnerio J, Ito K, Turka LA, Beck AH, Pinton P, Bronson RT, Wei W, Pandolfi PP. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell. 2014 Apr 24;157(3):595-610. doi: 10.1016/j.cell.2014.03.027.
- Zhi X, Chen C. WWP1: a versatile ubiquitin E3 ligase in signaling and diseases. Cell Mol Life Sci. 2012 May;69(9):1425-34. doi: 10.1007/s00018-011-0871-7. Epub 2011 Nov 4.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
8. Mai 2023 | Neueste Version
1 Feb 2021 | Ursprünglich veröffentlicht
Nehmen Sie an der Diskussion teil
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.